Global patent index - EP 0970055 A2

EP 0970055 A2 2000-01-12 - HIV PROTEASE INHIBITORS

Title (en)

HIV PROTEASE INHIBITORS

Title (de)

HIV PROTEASE INHIBITOREN

Title (fr)

INHIBITEURS DE LA PROTEASE DU VIH

Publication

EP 0970055 A2 (EN)

Application

EP 98910300 A

Priority

  • US 9804735 W
  • US 81595197 A

Abstract (en)

[origin: WO9840357A2] HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.

IPC 1-7 (main, further and additional classification)

C07D 217/22; A61K 31/47

IPC 8 full level (invention and additional information)

A61K 31/47 (2006.01); A61K 31/472 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); C07D 217/22 (2006.01); C07D 217/26 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01)

CPC (invention and additional information)

C07D 217/26 (2013.01)

Citation (search report)

See references of WO 9840357A2

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9840357 A2 19980917; WO 9840357 A3 19981126; AP 1358 A 20041203; AP 9901648 D0 19990930; AR 012556 A1 20001108; AU 6457598 A 19980929; AU 743078 B2 20020117; BG 103727 A 20000428; BG 63540 B1 20020430; BR 9808867 A 20000711; CA 2284163 A1 19980917; CN 1179948 C 20041215; CN 1253548 A 20000517; CO 4940496 A1 20000724; CZ 296647 B6 20060517; CZ 9903191 A3 20000614; EA 002378 B1 20020425; EE 04114 B1 20030815; EE 9900416 A 20000417; EP 0970055 A2 20000112; GE P20022764 B 20020510; HR P980112 A2 19981231; HU 0001380 A2 20000928; HU 0001380 A3 20011228; IL 131870 A 20060410; IL 131870 D0 20010319; IS 5176 A 19990910; JP 2001516350 A 20010925; MX PA99008395 A 20030812; MY 117535 A 20040731; NO 315555 B1 20030922; NO 994415 A 19991110; NO 994415 D0 19990910; NZ 337706 A 20010427; OA 11196 A 20030521; PA 8448801 A1 20000524; PE 58799 A1 19990712; PL 192786 B1 20061229; PL 335672 A1 20000508; SK 122299 A3 20000516; SK 283636 B6 20031104; SV 1998000038 A 19990215; TR 9902508 T2 20000221; ZA 9802047 B 19980928

INPADOC legal status

2010-10-29 [REG HK WD] APPLICATIONS WITHDRAWN, DEEMED TO BE WITHDRAWN, OR REFUSED AFTER PUBLICATION IN HONG KONG

- Ref Country Code: HK

- Ref Legal Event Code: WD

- Ref Document Number: 1026891

- Country of Ref Document: HK

2010-07-28 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20091229

2004-08-25 [RAP1] TRANSFER OF RIGHTS OF AN EP APPLICATION

- Owner name: AGOURON PHARMACEUTICALS, INC.

2004-08-25 [RAP1] TRANSFER OF RIGHTS OF AN EP APPLICATION

- Owner name: JAPAN TOBACCO INC.

2003-07-09 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20030523

2000-01-12 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19990910

2000-01-12 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

2000-01-12 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO

- Free Format Text: AL PAYMENT 19990910;LT PAYMENT 19990910;LV PAYMENT 19990910;MK PAYMENT 19990910;RO PAYMENT 19990910;SI PAYMENT 19990910